We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current BRKR market cap is 10.84B. The company's latest EPS is USD 3.1030 and P/E is 25.50.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 638.9M | 708.4M | 685.3M | 681.9M | 742.8M |
| Operating Income | 131.3M | 131M | 123.4M | 86.4M | 124.5M |
| Net Income | 88.1M | 97.4M | 76.5M | 57.1M | 88.1M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.07B | 1.99B | 2.42B | 2.53B | 2.96B |
| Operating Income | 300.9M | 250.4M | 412.8M | 432.7M | 442.6M |
| Net Income | 197.2M | 157.8M | 277.1M | 296.6M | 427.2M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.34B | 3.61B | 3.76B | 3.86B | 3.82B |
| Total Liabilities | 2.38B | 2.48B | 2.55B | 2.59B | 2.58B |
| Total Equity | 948M | 1.13B | 1.2B | 1.25B | 1.23B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.77B | 3.05B | 3.65B | 3.61B | 4.25B |
| Total Liabilities | 1.83B | 2.07B | 2.57B | 2.48B | 2.84B |
| Total Equity | 917.1M | 974.3M | 1.08B | 1.13B | 1.39B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 102.9M | 274.4M | 87.5M | 100.5M | 144.6M |
| Investing | -102.3M | -251.6M | -108.2M | -134.2M | -289.2M |
| Financing | -379.2M | -415.3M | -30.7M | -41M | -133.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 213.4M | 332.2M | 282.4M | 274.4M | 350.1M |
| Investing | -158.4M | -192.7M | -192.4M | -251.6M | -326M |
| Financing | 300M | -161.6M | 318.7M | -415.3M | -193.4M |
| Market Cap | 10.84B |
| Price to Earnings Ratio | 25.50 |
| Price to Sales Ratio | 3.67 |
| Price to Cash Ratio | 22.31 |
| Price to Book Ratio | 7.71 |
| Dividend Yield | 0.25% |
| Shares Outstanding | 137.67M |
| Average Volume (1 week) | 920.1k |
| Average Volume (1 Month) | 778.55k |
| 52 Week Change | -0.58% |
| 52 Week High | 94.86 |
| 52 Week Low | 53.79 |
| Spread (Intraday) | 0.06 (0.08%) |
| Company Name | Bruker Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.bruker.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
